Original data (with adjusted standard errors for multi-arm studies):

              treat1       treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
4           BZD-long    BZD-short -0.3034 0.2576     0.2576     0.3552     2         
6        eszopiclone      placebo  0.4040 0.1026     0.1026     0.2652     2         
8   BZD-intermediate      placebo  0.7214 0.2617     0.2617     0.3582     2         
9          BZD-short    zopiclone  0.2617 0.2826     0.2826     0.3738     2         
11  BZD-intermediate     BZD-long  0.2449 0.2207     0.2207     0.3295     2         
13          BZD-long      placebo  0.5533 0.2703     0.2703     0.3645     2         
18  BZD-intermediate      placebo -0.2722 0.2750     0.2750     0.3680     2         
19          BZD-long    BZD-short -0.7624 0.2797     0.2797     0.3716     2         
20          BZD-long    zopiclone  0.2187 0.1987     0.1987     0.3151     2         
23  BZD-intermediate     BZD-long -0.1025 0.1620     0.1966     0.3583     3        *
23  BZD-intermediate      placebo  0.5237 0.1663     0.2072     0.3641     3        *
23          BZD-long      placebo  0.6262 0.1624     0.1973     0.3587     3        *
24         BZD-short      placebo  1.1829 0.3131     0.3131     0.3974     2         
27          BZD-long    BZD-short -0.5141 0.1938     0.1938     0.3121     2         
30  BZD-intermediate      placebo  0.7610 0.2959     0.2959     0.3839     2         
31  BZD-intermediate     BZD-long -0.0984 0.2830     0.3415     0.4542     3        *
31          BZD-long      placebo  0.8068 0.2904     0.3595     0.4679     3        *
31  BZD-intermediate      placebo  0.7084 0.2887     0.3551     0.4646     3        *
36  BZD-intermediate      placebo  0.7540 0.1612     0.1612     0.2930     2         
39           placebo     zolpidem -0.4275 0.1239     0.1239     0.2742     2         
43           placebo     zaleplon -0.1360 0.1054     0.1054     0.2663     2         
44  BZD-intermediate      placebo  1.3538 0.2862     0.2862     0.3765     2         
47           placebo     zolpidem -1.2938 0.4804     0.4804     0.5391     2         
48          zaleplon     zolpidem -0.1046 0.1337     0.1337     0.2788     2         
50  BZD-intermediate     zolpidem -0.6721 0.3211     0.3211     0.4037     2         
58       eszopiclone      placebo  0.6757 0.0841     0.0841     0.2587     2         
60           doxepin      placebo  0.4235 0.1788     0.1788     0.3030     2         
62           placebo     zolpidem -0.2689 0.2027     0.2027     0.3177     2         
63           doxepin      placebo  0.1905 0.1258     0.1258     0.2751     2         
65         melatonin      placebo  0.3413 0.2160     0.2160     0.3263     2         
67  BZD-intermediate      placebo  1.7164 0.1167     0.1167     0.2710     2         
69          BZD-long    zopiclone -0.1541 0.3795     0.3795     0.4515     2         
70         melatonin      placebo -0.5156 0.3214     0.3214     0.4039     2         
71          BZD-long    BZD-short -0.0951 0.5777     0.5777     0.6273     2         
74          BZD-long    BZD-short -0.3055 0.3181     0.3181     0.4013     2         
75           placebo    ramelteon -0.0100 0.0942     0.0942     0.2621     2         
80           placebo     zolpidem -1.1824 0.6258     0.6258     0.6719     2         
81           placebo     zolpidem -1.1706 0.6248     0.6248     0.6710     2         
87           placebo     zolpidem -0.6219 0.3518     0.3518     0.4285     2         
94  BZD-intermediate     zolpidem  0.2380 0.3177     0.3177     0.4010     2         
99      daridorexant     zolpidem -0.0319 0.1579     0.1821     0.3506     3        *
99           placebo     zolpidem -0.2079 0.1828     0.2594     0.3876     3        *
99      daridorexant      placebo  0.1760 0.1581     0.1824     0.3508     3        *
100        melatonin      placebo  0.1894 0.1894     0.1894     0.3094     2         
102          placebo     zolpidem -0.6990 0.1965     0.1965     0.3137     2         
106      eszopiclone    zopiclone  0.0835 0.1419     0.1419     0.2828     2         
111 BZD-intermediate      placebo  1.0047 0.3468     0.4375     0.5297     3        *
111 BZD-intermediate trimipramine  0.2783 0.3300     0.3954     0.4958     3        *
111          placebo trimipramine -0.7264 0.3361     0.4091     0.5072     3        *
112          placebo     zolpidem -0.5690 0.2140     0.2140     0.3250     2         
113        BZD-short     zolpidem -0.0428 0.1458     0.1458     0.2847     2         
117       doxylamine     zolpidem -0.1000 0.1326     0.1589     0.3389     3        *
117          placebo     zolpidem -0.7000 0.1368     0.1687     0.3439     3        *
117       doxylamine      placebo  0.6000 0.1378     0.1713     0.3451     3        *
119          placebo     zolpidem -0.1815 0.2988     0.2988     0.3862     2         
120      eszopiclone      placebo  0.3387 0.1392     0.1392     0.2814     2         
121          placebo    trazodone -0.2430 0.2613     0.2613     0.3579     2         
123      eszopiclone      placebo  0.4555 0.2344     0.2344     0.3388     2         
124         BZD-long    zopiclone  0.0858 0.2066     0.2066     0.3202     2         
125         zolpidem    zopiclone  0.0625 0.0998     0.0998     0.2642     2         
127          placebo    ramelteon -0.1953 0.0651     0.0651     0.2531     2         
128 BZD-intermediate     zolpidem -0.0118 0.1432     0.1432     0.2835     2         
129        melatonin      placebo  0.1351 0.1096     0.1096     0.2680     2         
130        melatonin      placebo  0.2146 0.0746     0.0746     0.2557     2         
131 BZD-intermediate      placebo  0.2292 0.1108     0.1108     0.2685     2         
132          placebo    trazodone -0.2151 0.1414     0.1732     0.3460     3        *
132        trazodone     zolpidem  0.0331 0.1421     0.1751     0.3470     3        *
132          placebo     zolpidem -0.1820 0.1406     0.1712     0.3451     3        *
136      eszopiclone      placebo  0.7984 0.0760     0.0760     0.2562     2         
141         BZD-long      placebo  0.6878 0.2657     0.2657     0.3612     2         
142 BZD-intermediate      placebo  1.1456 0.3701     0.3701     0.4436     2         
143 BZD-intermediate    BZD-short -0.1607 0.1293     0.1293     0.2767     2         
144      eszopiclone      placebo  0.3309 0.1260     0.1260     0.2752     2         
145          placebo    ramelteon -0.1428 0.1219     0.1219     0.2733     2         
146      eszopiclone    zopiclone  0.0000 0.1333     0.1333     0.2786     2         
149 BZD-intermediate    trazodone -0.1438 0.1828     0.1828     0.3054     2         
159     daridorexant      placebo  0.2747 0.0699     0.0699     0.2544     2         
160     daridorexant      placebo  0.2498 0.0808     0.0808     0.2576     2         
161   diphenydramine      placebo  0.5306 0.1821     0.1821     0.3050     2         
162          placebo   quetiapine -0.0506 0.5564     0.5564     0.6078     2         
164 BZD-intermediate  mirtazapine -0.3261 0.2374     0.2374     0.3408     2         
170 BZD-intermediate  eszopiclone  0.1236 0.2159     0.2159     0.3262     2         

Number of treatment arms (by study):
    narms
4       2
6       2
8       2
9       2
11      2
13      2
18      2
19      2
20      2
23      3
24      2
27      2
30      2
31      3
36      2
39      2
43      2
44      2
47      2
48      2
50      2
58      2
60      2
62      2
63      2
65      2
67      2
69      2
70      2
71      2
74      2
75      2
80      2
81      2
87      2
94      2
99      3
100     2
102     2
106     2
111     3
112     2
113     2
117     3
119     2
120     2
121     2
123     2
124     2
125     2
127     2
128     2
129     2
130     2
131     2
132     3
136     2
141     2
142     2
143     2
144     2
145     2
146     2
149     2
159     2
160     2
161     2
162     2
164     2
170     2

Results (fixed effects model):

              treat1       treat2     SMD             95%-CI     Q leverage
4           BZD-long    BZD-short -0.2741 [-0.4403; -0.1079]  0.01     0.11
6        eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  2.96     0.15
8   BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.00     0.03
9          BZD-short    zopiclone  0.3446 [ 0.1608;  0.5283]  0.09     0.11
11  BZD-intermediate     BZD-long  0.1339 [-0.0149;  0.2827]  0.25     0.12
13          BZD-long      placebo  0.5742 [ 0.4298;  0.7186]  0.01     0.07
18  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009] 12.71     0.03
19          BZD-long    BZD-short -0.2741 [-0.4403; -0.1079]  3.05     0.09
20          BZD-long    zopiclone  0.0705 [-0.0937;  0.2347]  0.56     0.18
23  BZD-intermediate     BZD-long  0.1339 [-0.0149;  0.2827]  1.45        .
23  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.79        .
23          BZD-long      placebo  0.5742 [ 0.4298;  0.7186]  0.07        .
24         BZD-short      placebo  0.8483 [ 0.6898;  1.0068]  1.14     0.07
27          BZD-long    BZD-short -0.2741 [-0.4403; -0.1079]  1.53     0.19
30  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.03     0.03
31  BZD-intermediate     BZD-long  0.1339 [-0.0149;  0.2827]  0.46        .
31          BZD-long      placebo  0.5742 [ 0.4298;  0.7186]  0.42        .
31  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.00        .
36  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.08     0.09
39           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  0.85     0.13
43           placebo     zaleplon -0.2514 [-0.4172; -0.0856]  1.20     0.64
44  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  5.09     0.03
47           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  2.45     0.01
48          zaleplon     zolpidem -0.2903 [-0.4616; -0.1190]  1.93     0.43
50  BZD-intermediate     zolpidem  0.1665 [ 0.0531;  0.2798]  6.82     0.03
58       eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  1.28     0.23
60           doxepin      placebo  0.2676 [ 0.0659;  0.4693]  0.76     0.33
62           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  1.81     0.05
63           doxepin      placebo  0.2676 [ 0.0659;  0.4693]  0.38     0.67
65         melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.57     0.07
67  BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009] 74.67     0.16
69          BZD-long    zopiclone  0.0705 [-0.0937;  0.2347]  0.35     0.05
70         melatonin      placebo  0.1783 [ 0.0690;  0.2876]  4.66     0.03
71          BZD-long    BZD-short -0.2741 [-0.4403; -0.1079]  0.10     0.02
74          BZD-long    BZD-short -0.2741 [-0.4403; -0.1079]  0.01     0.07
75           placebo    ramelteon -0.1366 [-0.2327; -0.0404]  1.81     0.27
80           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  1.05     0.01
81           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  1.01     0.01
87           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  0.05     0.02
94  BZD-intermediate     zolpidem  0.1665 [ 0.0531;  0.2798]  0.05     0.03
99      daridorexant     zolpidem -0.2662 [-0.3928; -0.1396]  1.66        .
99           placebo     zolpidem -0.5417 [-0.6308; -0.4525]  1.66        .
99      daridorexant      placebo  0.2755 [ 0.1794;  0.3715]  0.30        .
100        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.00     0.09
102          placebo     zolpidem -0.5417 [-0.6308; -0.4525]  0.64     0.05
106      eszopiclone    zopiclone  0.0768 [-0.0586;  0.2122]  0.00     0.24
111 BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  0.46        .
111 BZD-intermediate trimipramine  0.1351 [-0.4240;  0.6941]  0.13        .
111          placebo trimipramine -0.5731 [-1.1323; -0.0138]  0.14        .
112          placebo     zolpidem -0.5417 [-0.6308; -0.4525]  0.02     0.05
113        BZD-short     zolpidem  0.3066 [ 0.1451;  0.4681]  5.75     0.32
117       doxylamine     zolpidem -0.0268 [-0.2588;  0.2052]  0.21        .
117          placebo     zolpidem -0.5417 [-0.6308; -0.4525]  0.88        .
117       doxylamine      placebo  0.5149 [ 0.2816;  0.7482]  0.25        .
119          placebo     zolpidem -0.5417 [-0.6308; -0.4525]  1.45     0.02
120      eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  3.02     0.08
121          placebo    trazodone -0.4973 [-0.6880; -0.3066]  0.95     0.14
123      eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  0.28     0.03
124         BZD-long    zopiclone  0.0705 [-0.0937;  0.2347]  0.01     0.16
125         zolpidem    zopiclone  0.0379 [-0.0972;  0.1731]  0.06     0.48
127          placebo    ramelteon -0.1366 [-0.2327; -0.0404]  0.81     0.57
128 BZD-intermediate     zolpidem  0.1665 [ 0.0531;  0.2798]  1.55     0.16
129        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.16     0.26
130        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.24     0.56
131 BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009] 18.69     0.18
132          placebo    trazodone -0.4973 [-0.6880; -0.3066]  2.66        .
132        trazodone     zolpidem -0.0443 [-0.2409;  0.1522]  0.20        .
132          placebo     zolpidem -0.5417 [-0.6308; -0.4525]  4.41        .
136      eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  8.21     0.28
141         BZD-long      placebo  0.5742 [ 0.4298;  0.7186]  0.18     0.08
142 BZD-intermediate      placebo  0.7081 [ 0.6153;  0.8009]  1.40     0.02
143 BZD-intermediate    BZD-short -0.1402 [-0.2979;  0.0175]  0.03     0.39
144      eszopiclone      placebo  0.5805 [ 0.5017;  0.6593]  3.92     0.10
145          placebo    ramelteon -0.1366 [-0.2327; -0.0404]  0.00     0.16
146      eszopiclone    zopiclone  0.0768 [-0.0586;  0.2122]  0.33     0.27
149 BZD-intermediate    trazodone  0.2108 [ 0.0128;  0.4088]  3.76     0.31
159     daridorexant      placebo  0.2755 [ 0.1794;  0.3715]  0.00     0.49
160     daridorexant      placebo  0.2755 [ 0.1794;  0.3715]  0.10     0.37
161   diphenydramine      placebo  0.5306 [ 0.1736;  0.8876]  0.00     1.00
162          placebo   quetiapine -0.0506 [-1.1412;  1.0400]  0.00     1.00
164 BZD-intermediate  mirtazapine -0.3261 [-0.7913;  0.1391]  0.00     1.00
170 BZD-intermediate  eszopiclone  0.1276 [ 0.0106;  0.2446]  0.00     0.08

Results (random effects model):

              treat1       treat2     SMD             95%-CI
4           BZD-long    BZD-short -0.3233 [-0.5783; -0.0684]
6        eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
8   BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
9          BZD-short    zopiclone  0.3926 [ 0.0741;  0.7111]
11  BZD-intermediate     BZD-long  0.1116 [-0.1291;  0.3523]
13          BZD-long      placebo  0.5713 [ 0.3416;  0.8009]
18  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
19          BZD-long    BZD-short -0.3233 [-0.5783; -0.0684]
20          BZD-long    zopiclone  0.0693 [-0.2053;  0.3438]
23  BZD-intermediate     BZD-long  0.1116 [-0.1291;  0.3523]
23  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
23          BZD-long      placebo  0.5713 [ 0.3416;  0.8009]
24         BZD-short      placebo  0.8946 [ 0.6256;  1.1636]
27          BZD-long    BZD-short -0.3233 [-0.5783; -0.0684]
30  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
31  BZD-intermediate     BZD-long  0.1116 [-0.1291;  0.3523]
31          BZD-long      placebo  0.5713 [ 0.3416;  0.8009]
31  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
36  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
39           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
43           placebo     zaleplon -0.2940 [-0.6792;  0.0913]
44  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
47           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
48          zaleplon     zolpidem -0.2776 [-0.6645;  0.1092]
50  BZD-intermediate     zolpidem  0.1113 [-0.0905;  0.3131]
58       eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
60           doxepin      placebo  0.2957 [-0.1034;  0.6949]
62           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
63           doxepin      placebo  0.2957 [-0.1034;  0.6949]
65         melatonin      placebo  0.1302 [-0.1336;  0.3941]
67  BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
69          BZD-long    zopiclone  0.0693 [-0.2053;  0.3438]
70         melatonin      placebo  0.1302 [-0.1336;  0.3941]
71          BZD-long    BZD-short -0.3233 [-0.5783; -0.0684]
74          BZD-long    BZD-short -0.3233 [-0.5783; -0.0684]
75           placebo    ramelteon -0.1172 [-0.4142;  0.1798]
80           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
81           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
87           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
94  BZD-intermediate     zolpidem  0.1113 [-0.0905;  0.3131]
99      daridorexant     zolpidem -0.2759 [-0.5922;  0.0403]
99           placebo     zolpidem -0.5716 [-0.7337; -0.4095]
99      daridorexant      placebo  0.2956 [ 0.0077;  0.5836]
100        melatonin      placebo  0.1302 [-0.1336;  0.3941]
102          placebo     zolpidem -0.5716 [-0.7337; -0.4095]
106      eszopiclone    zopiclone  0.0227 [-0.2540;  0.2993]
111 BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
111 BZD-intermediate trimipramine  0.1211 [-0.5784;  0.8205]
111          placebo trimipramine -0.5618 [-1.2617;  0.1381]
112          placebo     zolpidem -0.5716 [-0.7337; -0.4095]
113        BZD-short     zolpidem  0.3230 [ 0.0403;  0.6057]
117       doxylamine     zolpidem -0.0369 [-0.5175;  0.4436]
117          placebo     zolpidem -0.5716 [-0.7337; -0.4095]
117       doxylamine      placebo  0.5346 [ 0.0536;  1.0157]
119          placebo     zolpidem -0.5716 [-0.7337; -0.4095]
120      eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
121          placebo    trazodone -0.4996 [-0.8372; -0.1621]
123      eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
124         BZD-long    zopiclone  0.0693 [-0.2053;  0.3438]
125         zolpidem    zopiclone  0.0696 [-0.2130;  0.3522]
127          placebo    ramelteon -0.1172 [-0.4142;  0.1798]
128 BZD-intermediate     zolpidem  0.1113 [-0.0905;  0.3131]
129        melatonin      placebo  0.1302 [-0.1336;  0.3941]
130        melatonin      placebo  0.1302 [-0.1336;  0.3941]
131 BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
132          placebo    trazodone -0.4996 [-0.8372; -0.1621]
132        trazodone     zolpidem -0.0720 [-0.4243;  0.2804]
132          placebo     zolpidem -0.5716 [-0.7337; -0.4095]
136      eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
141         BZD-long      placebo  0.5713 [ 0.3416;  0.8009]
142 BZD-intermediate      placebo  0.6829 [ 0.5204;  0.8453]
143 BZD-intermediate    BZD-short -0.2117 [-0.4873;  0.0638]
144      eszopiclone      placebo  0.5247 [ 0.3302;  0.7191]
145          placebo    ramelteon -0.1172 [-0.4142;  0.1798]
146      eszopiclone    zopiclone  0.0227 [-0.2540;  0.2993]
149 BZD-intermediate    trazodone  0.1832 [-0.1652;  0.5317]
159     daridorexant      placebo  0.2956 [ 0.0077;  0.5836]
160     daridorexant      placebo  0.2956 [ 0.0077;  0.5836]
161   diphenydramine      placebo  0.5306 [-0.0671;  1.1283]
162          placebo   quetiapine -0.0506 [-1.2419;  1.1407]
164 BZD-intermediate  mirtazapine -0.3261 [-0.9941;  0.3420]
170 BZD-intermediate  eszopiclone  0.1582 [-0.0796;  0.3961]

Number of studies: k = 70
Number of pairwise comparisons: m = 82
Number of observations: o = 14165
Number of treatments: n = 18
Number of designs: d = 31

Fixed effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI     z  p-value
BZD-intermediate 0.7081 [ 0.6153; 0.8009] 14.96 < 0.0001
BZD-long         0.5742 [ 0.4298; 0.7186]  7.80 < 0.0001
BZD-short        0.8483 [ 0.6898; 1.0068] 10.49 < 0.0001
daridorexant     0.2755 [ 0.1794; 0.3715]  5.62 < 0.0001
diphenydramine   0.5306 [ 0.1736; 0.8876]  2.91   0.0036
doxepin          0.2676 [ 0.0659; 0.4693]  2.60   0.0093
doxylamine       0.5149 [ 0.2816; 0.7482]  4.33 < 0.0001
eszopiclone      0.5805 [ 0.5017; 0.6593] 14.44 < 0.0001
melatonin        0.1783 [ 0.0690; 0.2876]  3.20   0.0014
mirtazapine      1.0342 [ 0.5598; 1.5086]  4.27 < 0.0001
placebo               .                 .     .        .
quetiapine       0.0506 [-1.0400; 1.1412]  0.09   0.9275
ramelteon        0.1366 [ 0.0404; 0.2327]  2.78   0.0054
trazodone        0.4973 [ 0.3066; 0.6880]  5.11 < 0.0001
trimipramine     0.5731 [ 0.0138; 1.1323]  2.01   0.0446
zaleplon         0.2514 [ 0.0856; 0.4172]  2.97   0.0030
zolpidem         0.5417 [ 0.4525; 0.6308] 11.91 < 0.0001
zopiclone        0.5037 [ 0.3700; 0.6375]  7.38 < 0.0001

Random effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI    z  p-value            95%-PI
BZD-intermediate 0.6829 [ 0.5204; 0.8453] 8.24 < 0.0001 [ 0.1659; 1.1999]
BZD-long         0.5713 [ 0.3416; 0.8009] 4.87 < 0.0001 [ 0.0283; 1.1142]
BZD-short        0.8946 [ 0.6256; 1.1636] 6.52 < 0.0001 [ 0.3332; 1.4561]
daridorexant     0.2956 [ 0.0077; 0.5836] 2.01   0.0442 [-0.2755; 0.8668]
diphenydramine   0.5306 [-0.0671; 1.1283] 1.74   0.0819 [-0.2520; 1.3132]
doxepin          0.2957 [-0.1034; 0.6949] 1.45   0.1465 [-0.3414; 0.9329]
doxylamine       0.5346 [ 0.0536; 1.0157] 2.18   0.0294 [-0.1590; 1.2283]
eszopiclone      0.5247 [ 0.3302; 0.7191] 5.29 < 0.0001 [-0.0037; 1.0531]
melatonin        0.1302 [-0.1336; 0.3941] 0.97   0.3334 [-0.4287; 0.6891]
mirtazapine      1.0089 [ 0.3214; 1.6965] 2.88   0.0040 [ 0.1529; 1.8650]
placebo               .                 .    .        .                 .
quetiapine       0.0506 [-1.1407; 1.2419] 0.08   0.9336 [-1.2609; 1.3622]
ramelteon        0.1172 [-0.1798; 0.4142] 0.77   0.4391 [-0.4588; 0.6932]
trazodone        0.4996 [ 0.1621; 0.8372] 2.90   0.0037 [-0.0992; 1.0985]
trimipramine     0.5618 [-0.1381; 1.2617] 1.57   0.1156 [-0.3046; 1.4282]
zaleplon         0.2940 [-0.0913; 0.6792] 1.50   0.1348 [-0.3342; 0.9221]
zolpidem         0.5716 [ 0.4095; 0.7337] 6.91 < 0.0001 [ 0.0547; 1.0885]
zopiclone        0.5020 [ 0.2334; 0.7705] 3.66   0.0002 [-0.0592; 1.0632]

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0598; tau = 0.2446; I^2 = 70.1% [61.1%; 76.9%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                     Q d.f.  p-value
Total           197.01   59 < 0.0001
Within designs  154.18   40 < 0.0001
Between designs  42.83   19   0.0014
[1] "A total of 18 treatments are included in the network."
[1] "A total of 70 studies are included in this analysis."
[1] "Estimated heterogeneity tau-squared0.06"
[1] "Global test for inconsistency, p-value 0.00137 (Q=43, d.o.f. 19)"
[1] "File created on 2022-04-11"
